Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M York

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of the Medical Association of Georgia|May 1, 1987
The medical management of breast cancerR M York
Southern Medical Journal|March 1, 1981
Treatment of small cell lung cancerR M York
Cancer|June 1, 1988
Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanomaR M York, A T Foltz
Cancer|December 15, 1983
Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatinR M York, D H Lawson, J McKay
The American Journal of Medicine|October 1, 1987
Spontaneous remission of metastatic paragangliomaD W Nixon, R M York, F M McConnel
Cutis|February 1, 1981
Dermatologic changes after systemic cancer therapyD W Nixon, D Pirozzi, R M York, et al.
The Journal of Biological Chemistry|October 25, 1977
Cystine requirement of continuous human lymphoid cell lines of normal and leukemic originJ K Iglehart, R M York, A P Modest, et al.
Journal of the American Board of Family Medicine : JABFM|September 11, 2015
Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD StudyBonnie M Vest, Trevor R M York, Jessica Sand, et al.
American Journal of Clinical Pathology|August 1, 1982
Immunologic abnormalities in two patients with pulmonary hyalinizing granulomaD C Schlosnagle, I J Check, C W Sewell, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1991
Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancerM J Koretz, D H Lawson, R M York, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of the Medical Association of Georgia|May 1, 1987
The medical management of breast cancerR M York
Southern Medical Journal|March 1, 1981
Treatment of small cell lung cancerR M York
Cancer|June 1, 1988
Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanomaR M York, A T Foltz
Cancer|December 15, 1983
Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatinR M York, D H Lawson, J McKay
The American Journal of Medicine|October 1, 1987
Spontaneous remission of metastatic paragangliomaD W Nixon, R M York, F M McConnel
Cutis|February 1, 1981
Dermatologic changes after systemic cancer therapyD W Nixon, D Pirozzi, R M York, et al.
The Journal of Biological Chemistry|October 25, 1977
Cystine requirement of continuous human lymphoid cell lines of normal and leukemic originJ K Iglehart, R M York, A P Modest, et al.
Journal of the American Board of Family Medicine : JABFM|September 11, 2015
Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD StudyBonnie M Vest, Trevor R M York, Jessica Sand, et al.
American Journal of Clinical Pathology|August 1, 1982
Immunologic abnormalities in two patients with pulmonary hyalinizing granulomaD C Schlosnagle, I J Check, C W Sewell, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1991
Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancerM J Koretz, D H Lawson, R M York, et al.
Pageof 2